The global cardiac assist devices market size was valued at USD 2.7 billion in 2021, growing at a CAGR of 13.6% during the forecast period 2022 to 2028.Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Cardiac Assist Devices Market: By type of product ( Ventricular Assist Devices (VDS) (External Ventricular Assist Devices, Left Ventricular Assist Devices (LVDS), Biventricular Assist Devices, Right Ventricular Assist Devices) Intra-Aortic Balloon Pumps, Total Artificial Heart)) By on flow rate (Continuous Flow, Pulsatile) By end user (Hospitals, Ambulatory Surgical Centres, Others) Geography - Global/Region/Country Forecast to 2027”

View Detailed Report Description https://precisionbusinessinsights.com/market-reports/cardiac-assist-devices-market/  

A cardiac assist device is a mechanical pump that helps people with weaker hearts as well as it also helps to maintain blood circulation flow in the heart. Additionally, the cardiac assist device pulls blood from a lower chamber of the heart and pump it to the body and organ systems. These devices may be used to partially or entirely transplant the heart. The Cardiac Assist Devices Market is expected to rise over the projected period, primarily owing to greater patient awareness of heart failure and the provision of improved treatment alternatives.

During the forecast period of 2020-2025, the introduction of next-generation cardiac assist devices is likely to boost growth of the industry. With considerable improvements in design concepts and process conditions, the market has seen the launch of various new and unique heart assist devices. Surgeons are using less intrusive technologies to execute Left Ventricular Assist Device (LVAD) implant procedures more efficiently. Furthermore, the worldwide cardiac assist devices market is expected to expand over the assessment period as a result of technical developments, product launch approvals, ageing population, and improved reimbursement policies for heart failure and associated comorbidities. Vendors are anticipated to concentrate on untapped patient needs as demand for novel cardiac assist devices rises due to reassuring clinical outcomes, resulting in more possibilities for vendors.

Request sample: https://precisionbusinessinsights.com/request-sample?product_id=18622    

Impact of COVID-19 on Cardiac Assist Devices Market:
In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years.

Based on product, it is fragmented into Total Artificial Heart, Intra-aortic Balloon Pump, and Ventricular Assist Device. Heart transplantation is the most efficient treatment for end-stage heart failures. Universally, there has been a rise in the demand particularly for donor organs. During the projection period, the hospital segment is likely to gain market share, as the medical facilities providing cardiac care is significantly higher compared to other healthcare venues. Because of their accessible locations and simplicity of access, patients choose to receive advanced heart failure medication at hospitals. Patients with a variety of CVDs, such as vascular stenosis and heart failure, are treated exclusively in Specialty Cardiac Centers (SSCs). Due to the availability of advanced infrastructure, this segment is predicted to develop at the highest CAGR.

Owing to the technological improvements and the rising prevalence of cardiac illnesses, the North American area is a prominent contributor to this market. As per the Centers for Disease Control and Prevention (CDC), heart ailment is expected to kill over 645,000 Americans every year. As the number of people suffering from heart disease rises, so does the need. In the United States, around 25% of all LVAD implants are conducted, and the volume of implants is rising year after year. As a result of the increasing acceptance rate for these devices, the cardiac assist devices market is predicted to grow drastically throughout the forecast timeframe.

Some of the major key players in the cardiac assist devices market are Calon Cardio-Technology Ltd. (UK) SynCardia Systems, Inc. (U.S.), Medtronic (U.S.), Berlin Heart GmbH (Germany), CHF Solutions, Inc. (U.S.), Teleflex Incorporated (U.S.), MAQUET GmbH & Co. (Germany), Abiomed (U.S.) and Abbot Laboratories (U.S.).

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights| Toll Free: +1 866 598 1553

Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747